Related Experiment Video
Updated: Aug 10, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Hypertension: pathophysiologic-based management. Part II
1U.P.R. School of Medicine.
Insights
Common hypertension drugs like diuretics and beta-blockers can negatively impact metabolic health, reducing their cardiovascular benefits. Alternative antihypertensives that improve risk factors such as diabetes and dyslipidemia are recommended for better heart health.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Metabolic Health
Background:
- Hypertension management is crucial for reducing cardiovascular disease (CVD) risk.
- Diuretics and beta-blockers are widely used antihypertensive therapies.
- These common treatments can lead to adverse metabolic and biochemical changes.
Purpose of the Study:
- To evaluate the impact of diuretic and beta-blocker therapy on CVD risk factors.
- To identify potential limitations of these therapies in managing overall cardiovascular risk.
- To recommend alternative antihypertensive strategies.
Main Methods:
- Review of existing literature on hypertension pharmacotherapy.
- Analysis of metabolic and biochemical alterations associated with diuretics and beta-blockers.
- Comparative assessment of different antihypertensive drug classes regarding cardiovascular risk factor modification.
Main Results:
- Diuretic and beta-blocker therapies induce metabolic alterations.
- These alterations can counteract the benefits of blood pressure reduction for coronary artery disease risk.
- The extent of metabolic impact varies among different agents within these classes.
Conclusions:
- Standard hypertension therapies (diuretics, beta-blockers) may have unintended metabolic consequences.
- These consequences can diminish the net protective effect against cardiovascular events.
- Antihypertensive medications that positively influence diabetes and dyslipidemia should be prioritized.
Abstract:
The therapy for hypertension utilizing diuretics and beta-blockers induces metabolic and biochemical alterations that blunt the possible beneficial effects of blood pressure reduction in coronary artery disease risk. The utilization of other antihypertensive medications with the capacity of improving cardiovascular risk factors, like diabetes and dyslipidemias is recommended.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

